drugset / Trial / NCT00447837
Evaluating SPRC-AB01 in Post-Surgical Subjects With Chronic Sinusitis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The primary objective of the study is to evaluate the safety and efficacy of SPRC-AB01 versus placebo for treatment of chronic sinusitis in subjects who have had sinus surgery.
Timeline
- Start
- 2006-10
- Primary completion
- 2007-12
- Completion
- 2008-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tobramycin | Small molecule | 90 mg | Inhaled |
| Subject | Tobramycin | Small molecule | 180 mg | Inhaled |